BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Lungulescu C, Scripcariu DV, Stolniceanu CR, Konsoulova-Kirova AA, Grigorescu C, Stefanescu C, Volovat CC, Augustin I. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Front Oncol 2020;10:526850. [PMID: 33330019 DOI: 10.3389/fonc.2020.526850] [Cited by in Crossref: 8] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Villarreal-garcía V, Estupiñan-jiménez JR, Vivas-mejía PE, Gonzalez-villasana V, Vázquez-guillén JM, Reséndez-pérez D. A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs. Front Oncol 2022;12:980694. [DOI: 10.3389/fonc.2022.980694] [Reference Citation Analysis]
2 Hwang YS, Park ES, Oh BM, Uhm TG, Yoon SR, Park J, Cho HJ, Lee HG. miR-302 Suppresses the Proliferation, Migration, and Invasion of Breast Cancer Cells by Downregulating ATAD2. Cancers 2022;14:4345. [DOI: 10.3390/cancers14184345] [Reference Citation Analysis]
3 Cai B, Xia Z, Wang J, Wu S, Jin X. Reduced Graphene Oxide-Based Field Effect Transistor Biosensors for High-Sensitivity miRNA21 Detection. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c03372] [Reference Citation Analysis]
4 Di K, Fan B, Gu X, Huang R, Khan A, Liu C, Shen H, Li Z. Highly efficient and automated isolation technology for extracellular vesicles microRNA. Front Bioeng Biotechnol 2022;10:948757. [DOI: 10.3389/fbioe.2022.948757] [Reference Citation Analysis]
5 Wang S, Yin N, Li Y, Xiang T, Jiang W, Zhao X, Liu W, Zhang Z, Shi J, Zhang K, Guo X, Si P, Liu J. Copper-based metal–organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01520-8] [Reference Citation Analysis]
6 Pang X, Zhang Q, Li S, Zhao J, Cai M, Wang H, Xu H, Yang G, Shan Y. Spatiotemporal tracking of the transport of RNA nano-drugs: from transmembrane to intracellular delivery. Nanoscale 2022;14:8919-28. [PMID: 35699091 DOI: 10.1039/d2nr00988a] [Reference Citation Analysis]
7 Hu X, Zhang Q, Xing W, Wang W. Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer. Front Pharmacol 2022;13:814971. [DOI: 10.3389/fphar.2022.814971] [Reference Citation Analysis]
8 Wang Y, Li C, Asghar MZ. lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer via Regulation of miR-377-3p/GRSF1 Signaling Axis. Computational and Mathematical Methods in Medicine 2022;2022:1-15. [DOI: 10.1155/2022/8366569] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Xiu Y, Cao S, Jiang R, Zhou Y. lncRNA LINC01315 promotes malignancy of triple-negative breast cancer and predicts poor outcomes by modulating microRNA-876-5p/GRK5. Bioengineered 2022;13:10001-9. [PMID: 35412954 DOI: 10.1080/21655979.2022.2062536] [Reference Citation Analysis]
10 Li L, Gan YP, Peng H. RAMP2-AS1 inhibits CXCL11 expression to suppress malignant phenotype of breast cancer by recruiting DNMT1 and DNMT3B. Exp Cell Res 2022;:113139. [PMID: 35390315 DOI: 10.1016/j.yexcr.2022.113139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yang X, Cao D, Ma W, Gao S, Wen G, Zhong J. Wnt signaling in triple-negative breast cancers: Its roles in molecular subtyping and cancer cell stemness and its crosstalk with non-coding RNAs. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Badoual C. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx. Head Neck Pathol 2022. [PMID: 35312986 DOI: 10.1007/s12105-022-01449-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Baranova A, Krasnoselskyi M, Starikov V, Kartashov S, Zhulkevych I, Vlasenko V, Oleshko K, Bilodid O, Sadchikova M, Vinnyk Y. Triple-negative breast cancer: current treatment strategies and factors of negative prognosis. J Med Life 2022;15:153-61. [PMID: 35419095 DOI: 10.25122/jml-2021-0108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Lin CY, Tseng WT, Chang YY, Tsai MH, Chuang EY, Lu TP, Lai LC. Lidocaine and Bupivacaine Downregulate MYB and DANCR lncRNA by Upregulating miR-187-5p in MCF-7 Cells. Front Med (Lausanne) 2021;8:732817. [PMID: 35096852 DOI: 10.3389/fmed.2021.732817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Chen Q, Yang Z, Ding H, Li H, Wang W, Pan Z. CircWHSC1 Promotes Breast Cancer Progression by Regulating the FASN/AMPK/mTOR Axis Through Sponging miR-195-5p. Front Oncol 2021;11:649242. [PMID: 35070947 DOI: 10.3389/fonc.2021.649242] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Deshpande RP, Sharma S, Liu Y, Pandey PR, Pei X, Wu K, Wu SY, Tyagi A, Zhao D, Mo YY, Watabe K. LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c. Breast Cancer Res 2022;24:6. [PMID: 35078502 DOI: 10.1186/s13058-022-01504-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Zhang S, Xu J, Cao H, Jiang M, Xiong J. KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling. Front Oncol 2022;11:808291. [DOI: 10.3389/fonc.2021.808291] [Reference Citation Analysis]
18 Li X, Ren Y, Liu D, Yu X, Chen K. Role of miR-100-5p and CDC25A in breast carcinoma cells. PeerJ 2022;9:e12263. [PMID: 35036112 DOI: 10.7717/peerj.12263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Toden S, Goel A. Non-coding RNAs as liquid biopsy biomarkers in cancer. Br J Cancer. [DOI: 10.1038/s41416-021-01672-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
20 Wu M, Wen L, Zhou Y, Wu W. Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity. Technol Cancer Res Treat 2022;21:15330338221085361. [PMID: 35369814 DOI: 10.1177/15330338221085361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zong Y, Pegram M. Research advances and new challenges in overcoming triple-negative breast cancer. Cancer Drug Resist 2021;4:517-42. [PMID: 34888495 DOI: 10.20517/cdr.2021.04] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Cavallari I, Ciccarese F, Sharova E, Urso L, Raimondi V, Silic-Benussi M, D'Agostino DM, Ciminale V. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers (Basel) 2021;13:5874. [PMID: 34884985 DOI: 10.3390/cancers13235874] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
23 Park JE, Kim HW, Yun SH, Kim SJ. Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation. J Ginseng Res 2021;45:754-62. [PMID: 34764730 DOI: 10.1016/j.jgr.2021.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pu J, Zhang Y, Wang A, Qin Z, Zhuo C, Li W, Xu Z, Tang Q, Wang J, Wei H. ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis. Front Oncol 2021;11:754835. [PMID: 34733789 DOI: 10.3389/fonc.2021.754835] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 da Silva FC, de Melo Neto AB, Martins CA, de Sousa Cardoso TC, de Souza Gomes M, de Araújo TG, Fürstenau CR. Is the regulation by miRNAs of NTPDase1 and ecto-5'-nucleotidase genes involved with the different profiles of breast cancer subtypes? Purinergic Signal 2021. [PMID: 34741235 DOI: 10.1007/s11302-021-09824-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Haque S, Cook K, Sahay G, Sun C. RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer. Pharmaceutics 2021;13:1694. [PMID: 34683988 DOI: 10.3390/pharmaceutics13101694] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
27 Mirzaei S, Paskeh MDA, Hashemi F, Zabolian A, Hashemi M, Entezari M, Tabari T, Ashrafizadeh M, Raee P, Aghamiri S, Aref AR, Leong HC, Kumar AP, Samarghandian S, Zarrabi A, Hushmandi K. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies. Life Sci 2021;:119948. [PMID: 34520771 DOI: 10.1016/j.lfs.2021.119948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
28 Qin S, Ning M, Liu Q, Ding X, Wang Y, Liu Q. Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis. Bioengineered 2021;12:5125-37. [PMID: 34374638 DOI: 10.1080/21655979.2021.1962685] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
29 Yi X, He Z, Tian T, Kou Z, Pang W. LncIMF2 promotes adipogenesis in porcine intramuscular preadipocyte through sponging MiR-217. Anim Biotechnol 2021;:1-12. [PMID: 34346296 DOI: 10.1080/10495398.2021.1956509] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Tang W, Zhu S, Liang X, Liu C, Song L. The Crosstalk Between Long Non-Coding RNAs and Various Types of Death in Cancer Cells. Technol Cancer Res Treat 2021;20:15330338211033044. [PMID: 34278852 DOI: 10.1177/15330338211033044] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
31 Fontemaggi G, Turco C, Esposito G, Di Agostino S. New Molecular Mechanisms and Clinical Impact of circRNAs in Human Cancer. Cancers (Basel) 2021;13:3154. [PMID: 34202482 DOI: 10.3390/cancers13133154] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
32 Mathias C, Muzzi JCD, Antunes BB, Gradia DF, Castro MAA, Carvalho de Oliveira J. Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes. Front Oncol 2021;11:692170. [PMID: 34136413 DOI: 10.3389/fonc.2021.692170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sun J, Li X, Yu E, Liu J, Sun L, He Q, Lu Q. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer. Diagn Pathol 2021;16:45. [PMID: 34006305 DOI: 10.1186/s13000-021-01105-3] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
34 Xu H, Yang Y, Fan L, Deng L, Fan J, Li D, Li H, Zhao RC. Lnc13728 facilitates human mesenchymal stem cell adipogenic differentiation via positive regulation of ZBED3 and downregulation of the WNT/β-catenin pathway. Stem Cell Res Ther 2021;12:176. [PMID: 33712067 DOI: 10.1186/s13287-021-02250-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Li J, Qi D, Hsieh TC, Huang JH, Wu JM, Wu E. Trailblazing perspectives on targeting breast cancer stem cells. Pharmacol Ther 2021;223:107800. [PMID: 33421449 DOI: 10.1016/j.pharmthera.2021.107800] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]